Soliqua 100 33 insulin combination therapy?

Soliqua 100/33 is an insulin glargine + lixisenatide combination used to improve blood sugar in adults with type 2 diabetes. It helps lower fasting glucose (insulin glargine) and post-meal glucose (lixisenatide).

What it contains

• Insulin glargine (100 units/mL) – long-acting basal insulin
• Lixisenatide (33 mcg/mL) – a GLP-1 receptor agonist (slows gastric emptying and increases insulin release in a glucose-dependent way)

Typical use

• Usually taken once daily, typically within 1 hour before the first meal of the day.
• Often started at a lower dose and titrated upward based on your glucose and A1C results.

(Exact titration depends on your prior diabetes meds, A1C, and clinician guidance.)

Common side effects

From insulin/GLP-1 effects

• Nausea (often early with lixisenatide)
• Vomiting or diarrhea
• Decreased appetite
• Injection-site reactions
• Low blood sugar (hypoglycemia)—risk increases if used with other glucose-lowering drugs (especially sulfonylureas or other insulins)

Serious / important risks to know

• Hypoglycemia (watch for sweating, shakiness, confusion)
• Pancreatitis (severe abdominal pain that may radiate to the back)
• Gallbladder disease (right upper abdominal pain, fever, jaundice)
• Kidney issues, sometimes from dehydration related to GI side effects
• Thyroid C-cell tumor risk: boxed warning (contraindicated/avoided in people with personal/family history of medullary thyroid cancer or MEN2)

Who should not use it (or needs extra caution)

• History of medullary thyroid carcinoma or MEN2
• Prior serious hypersensitivity to either component
• Use caution with severe GI disease or previous pancreatitis (discuss with your clinician)
• If you have renal impairment, your clinician may adjust monitoring/approach

Drug interactions (practical points)

• Other diabetes meds: may increase hypoglycemia risk (dose adjustments often needed)
• Oral medications: because GLP-1 slows stomach emptying, it can affect absorption for some drugs—your prescriber may adjust timing.

Monitoring

• Home blood glucose (fasting and possibly post-meal, depending on your plan)
• A1C every ~3 months until stable
• Watch kidney function if you develop significant vomiting/diarrhea/dehydration

If you tell me:

1. your current dose (if you’re already on it),
2. what other diabetes medications you take (metformin, sulfonylurea, etc.), and
3. your main goal (A1C lowering vs fasting vs after meals),

…I can help you understand how Soliqua is typically titrated and what side effects to watch for based on your situation.